On the morning of the 30th September 2020, at the hall on 8th floor VNCC building, Japan Vietnam Medical Instrument J.S. Company (stock code: JVC) successfully held the 2020 Annual General Meeting of Shareholders.

At the meeting, the shareholders listened, discussed and voted through important company contents such as the 2019 performance report of the Board of Directors, the Board of Directors, and the Supervisory Board; Audited Financial Report 2019; The plan to pay remuneration to the members of the Board of Directors and the Supervisory Board in 2019 and the plan for 2020; ...

2019 is a difficult and challenging year for JVC when operating and ensuring safety for all employees due to the specific contact with medical facilities, to maintain even speed up supply when foreign trade is interrupted, customers postpone project cancellation ... That is the difficulty, but JVC still achieved some results: Net revenue reached 517 billion, reaching 74% of the plan, profit after tax reached 2.8 billion VND, 16% of the plan. On the other hand, the Company has recovered 1.7 billion of old debts, bad debts, and made provisions over the period. In 2019, in addition to the traditional diagnostic imaging instruments segment, JVC has taken positive steps in developing the infection control instruments segment by becoming the exclusive distributor of disinfectant products. Novaerus gas, supplies controlling infection Saraya, Dentalife.

In 2020, the company sets an aim to reach 520 billion VND in revenue and 5 billion VND in pre-tax profit with the following orientations and strategies:

- For the business of medical instruments and consumable materials: The company aims to expand its products to provide comprehensive solutions, instruments and consumables for specialized departments such as : imaging department, functional exploration department, department of resuscitation anesthesia, operating room and infection control department;

      - For associated investment activities: The Company will accelerate the implementation of new joint venture projects based on a comprehensive assessment of the effectiveness and development potential.

     - For technical services: The company aims to improve the quality of after-sales service through warranty and medical instruments maintenance contracts.

     - For mobile health check-up services: The company will deploy new examination models in collaboration with leading specialized and general hospitals, expanding service types and customers.

About senior personnel:

The General Meeting has elected members of the Board of Directors in the form of cumulative voting and secret ballot. List of elected:

      - Mr Nguyen Huy Tuan

      - Mr Nguyen Viet Cuong

      - Mr Vu Hoang Viet

The Congress elects members of the Supervisory Board in the form of cumulative voting and secret ballot. List of elected:

      - Mr Nguyen Le Thang

      - Mr Tran Duc Thanh